| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $38K | -56.1% |
| Cost of Revenue | $60K | -35.3% |
| Gross Profit | -$23K | -207.4% |
| R&D Expense | $6.0M | -2.6% |
| SG&A Expense | $3.8M | +4.4% |
| Operating Income | -$10.9M | +1.2% |
| Income Tax | $1K | — |
| Net Income | -$10.6M | -1.5% |
| EPS (Basic) | -$1.16 | +9.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.1M | -61.3% |
| Accounts Receivable | $24K | +3368.2% |
| Inventory | $10K | -89.9% |
| Current Assets | $6.5M | -59.9% |
| Total Assets | $10.0M | -49.3% |
| Current Liabilities | $973K | +73.5% |
| Total Liabilities | $2.2M | +10.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | -4.5% |
| Capital Expenditures | $119K | -39.4% |
| Investing Cash Flow | -$449K | +11.2% |
| Financing Cash Flow | -$129K | -100.8% |
| Free Cash Flow | -$9.3M | -3.5% |
| $7.9M |
| -55.9% |